Free Trial
→ Blackrock’s Sending THIS Crypto Higher on Purpose (From Crypto 101 Media) (Ad) Free SLS Stock Alerts

SELLAS Life Sciences Group (SLS) SEC Filings & 10K Form

SELLAS Life Sciences Group logo
$1.22 -0.03 (-2.02%)
(As of 10:39 AM ET)
Compare

Recent SELLAS Life Sciences Group SEC Filings

Export to Excel
DateFilerForm TypeView
11/13/2024
3:17 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/13/2024
3:01 PM		SELLAS Life Sciences Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/08/2024
7:33 AM		HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
SELLAS Life Sciences Group (Subject)
Form SC 13G/A
10/04/2024
3:06 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/13/2024
3:12 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2024
3:42 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/21/2024
3:26 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:06 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/14/2024
3:01 PM		SELLAS Life Sciences Group (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/01/2024
11:16 PM		SELLAS Life Sciences Group (Filer)
Form EFFECT
05/01/2024
11:16 PM		SELLAS Life Sciences Group (Filer)
Form EFFECT
04/29/2024
3:16 PM		SELLAS Life Sciences Group (Filer)
Form S-3/A
03/28/2024
3:46 PM		SELLAS Life Sciences Group (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/28/2024
3:51 PM		SELLAS Life Sciences Group (Filer)
Form S-3
Registration statement under Securities Act of 1933  
03/28/2024
3:08 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/28/2024
3:01 PM		SELLAS Life Sciences Group (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
03/28/2024
7:45 AM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/18/2024
3:37 PM		SELLAS Life Sciences Group (Filer)
Form 424B5
02/07/2024
2:01 PM		HIGHBRIDGE CAPITAL MANAGEMENT LLC (Filed by)
SELLAS Life Sciences Group (Subject)
Form SC 13G
01/25/2024
5:00 AM		Burns John Thomas (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:00 AM		SELLAS Life Sciences Group (Issuer)
VAN NOSTRAND ROBERT L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:01 AM		SELLAS Life Sciences Group (Issuer)
Varian John (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:02 AM		Francomano Robert (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:02 AM		SELLAS Life Sciences Group (Issuer)
Wasman Jane (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:03 AM		Kalin Katherine Bach (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:03 AM		SELLAS Life Sciences Group (Issuer)
WOOD BARBARA A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:03 AM		SCHEINBERG DAVID A (Reporting)
SELLAS Life Sciences Group (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/25/2024
5:04 AM		SELLAS Life Sciences Group (Issuer)
Stergiou Angelos M. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/08/2024
4:07 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/05/2024
3:27 PM		SELLAS Life Sciences Group (Filer)
Form 424B5
01/03/2024
4:25 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
8:05 AM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2023
3:21 PM		SELLAS Life Sciences Group (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
(Data available from 1/1/2016 forward)


Related Companies and Tools

Related Companies
SEC Filings Tools

This page (NASDAQ:SLS) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners
Missed Nvidia? Watch this ASAP
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored
Unveiled: NVIDIA’s "Secret Royalty" Program
Did you know that there's an investment that will give you the opportunity to collect "royalties" every time N...
Behind the Markets | Sponsored
Elon knows the truth, which is why they want him silenced
Elon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...
Porter & Company | Sponsored
$2 Trillion Disappears Because of Fed's Secretive New Move
$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...
Stansberry Research | Sponsored
24/7 Automated Profits in Crypto
The 4th quarter of 2024 is shaping up to be one of the most explosive periods for crypto in recent memory. But...
Crypto Swap Profits | Sponsored
Trump Wins… But Elon Says Get Ready to Brace
Trump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...
Genesis Gold Group | Sponsored